17 studies found for:    Open Studies | "Respiratory Syncytial Virus Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Respiratory Syncytial Virus Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infection
Conditions: Respiratory Syncytial Virus Infections;   Virus Diseases
Interventions: Drug: JNJ-53718678;   Drug: Placebo
2 Recruiting A Study of AK0529 in Infants Hospitalized With RSV
Condition: Respiratory Syncytial Virus Infections
Intervention: Drug: AK0529
3 Not yet recruiting Viral Inhibition in Children for Treatment of RSV
Condition: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Interventions: Drug: AK0529;   Drug: Placebo
4 Recruiting Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy
Conditions: Lower Respiratory Tract Infection;   Respiratory Syncytial Virus Infections
Intervention:
5 Recruiting A Study of Protective Immunity Against RSV and Influenza in Experimental Human Challenge of Volunteers
Conditions: Respiratory Syncytial Virus Infections;   Influenza, Human
Interventions: Biological: RSV A Memphis 37;   Biological: Influenza A/California/04/2009
6 Not yet recruiting Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy Women
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV vaccine GSK3003891A;   Biological: Boostrix
7 Not yet recruiting A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: ALS-008176;   Drug: Placebo
8 Recruiting A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV F vaccine with adjuvant;   Biological: Formulation buffer
9 Recruiting Safety and Immunogenicity of the RSV D46cpΔM2-2 Vaccine in RSV-Seropositive Children and RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: D46cpΔM2-2 vaccine;   Biological: Placebo
10 Recruiting A Study of ALS-008176 in Infants Hospitalized With RSV
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: ALS-008176;   Drug: Placebo
11 Recruiting Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine;   Biological: Placebo (1x Leibovitz L-15 medium)
12 Recruiting Prospective, Study for the Use of Palivizumab (Synagis) in High Risk Children in Germany
Condition: Respiratory Syncytial Virus Infections
Intervention:
13 Unknown  Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients
Conditions: Respiratory Distress Syndrome, Adult;   Respiratory Syncytial Virus Infections;   Pneumonia;   Acute Lung Injury
Intervention:
14 Recruiting Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract
Condition: Respiratory Syncytial Virus
Interventions: Drug: Presatovir;   Drug: Placebo
15 Recruiting Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study
Condition: Respiratory Syncytial Virus (RSV) Infection
Interventions: Drug: BTA-C585 oral capsule;   Drug: Matching placebo capsules
16 Recruiting TGF-(Beta) and Susceptibility to RSV
Conditions: Respiratory Syncytial Virus;   Asthma
Intervention:
17 Unknown  RSV Disease in the Elderly
Conditions: Respiratory Infections, Acute;   Respiratory Syncytial Virus
Intervention:

Indicates status has not been verified in more than two years